Institutional & Family Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Institutional & Family Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-753	Closed	-$106K	–	849
2019 Q2	$106K	Sell	753 -738	-49%	-$102K	0.02%	218
2019 Q1	$225K	Hold	1,491	–	–	0.05%	170
2018 Q4	$185K	Sell	1,491 -3,316	-69%	-$453K	0.04%	169
2018 Q3	$762K	Buy	4,807 +3,128	+186%	+$473K	0.15%	97
2018 Q2	$235K	Buy	1,679 +738	+78%	+$101K	0.05%	170
2018 Q1	$125K	Buy	+941	New	+$128K	0.03%	210
2017 Q1	–	Sell	-2,450	Closed	-$223K	–	127
2016 Q4	$223K	Buy	+2,450	New	+$229K	0.07%	118

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Institutional & Family Asset Management's FBT Position: Q3 2019 in Review

Institutional & Family Asset Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2019, closing a stake of 753 shares — an estimated $106K sold.

Institutional & Family Asset Management first reported a position in FBT in Q4 2016 and held it in 7 quarters. The position peaked at $762K in Q3 2018. 188 funds tracked by Wall St. Rank hold FBT as of Q3 2019.

Institutional & Family Asset Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2019 after selling out during the quarter.
Institutional & Family Asset Management sold 753 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2019, an estimated $106K.
Institutional & Family Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2016 and held it in 7 quarters.
Institutional & Family Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $762K in Q3 2018.
188 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2019.

Based on Institutional & Family Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.